Private Equity

Mid-market

Biotech desert

Tough times loom for the European biotechnology sector as investors flee and funding becomes increasingly difficult to attract. With companies collapsing, the next 12 months could make or break the life sciences industry.

8 min read · 01 October 2008

Fading light

Historically home to one of Europe’s most buoyant venture capital communities, the Nordic region is now facing the same shortage of funding as elsewhere on the Continent as limited partners rein in their commitments.

9 min read · 01 October 2008

Earlybird misses the worm

When the Hamburg and Munich-based venture capital manager Earlybird missed the fundraising target on its latest fund in August, it seemed to speak volumes about investors’ scepticism towards venture capital in Germany.

4 min read · 01 October 2008

Close Bros sells BWA

1 min read · 01 October 2008

AXA sells Saur slither

1 min read · 01 October 2008

Growing opportunity

Despite a dearth of debt available for leveraged buyouts, expansion capital abounds, but is still misunderstood by many SMEs. Scott Collins, managing director Summit Partners, makes the case for growth equity.

4 min read · 01 October 2008

Oxford Capital sells Infobasis

1 min read · 01 September 2008

Mid-market hit by crunch

A year ago, the consensus was that private equity firms which operated outside of the mega-deal bracket would have a much easier time of it. But, as the threat of recession looms, not even the mid-market can escape.

4 min read · 01 September 2008

Out of Ireland

For years an insular market, Irish venture capital is making the first tentative steps towards internationalisation as it comes out of its shell and not only attracts foreign investors, but also looks to invest abroad as well.

8 min read · 01 September 2008

Centre Partners Buys Operator Of Nursing Homes

2 min read · 04 August 2008

Showing 421 to 430 of 653 results
1…4244…66